Cashu | Summary

DJI

-1.23%

SPX

-1.60%

IXIC

-2.24%

FTSE

-0.70%

N225

-0.66%

AXJO

-0.92%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

-1.23%

SPX

-1.60%

IXIC

-2.24%

FTSE

-0.70%

N225

-0.66%

AXJO

-0.92%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

76.85M

Dividend Yield

0.00%

P/E Ratio

-4.12

EPS

-2.03

Revenue

9.74M

Avg. Volume

2.72M

About

What does CRVO do?

CervoMed, a Boston-based biotechnology company with 8 employees, focuses on developing neflamapimod for neurodegenerative diseases and is conducting the RewinD-LB Phase 2b trial for dementia with Lewy bodies. The drug aims to modify disease processes and improve synaptic dysfunction.

Sector

💻 Health Care

IPO

CEO

Employees

15 employees

Headquarters

Virginia, USA

Website

http://www.diffusionpharma.com